Rare diseases
Investigational molecules
Locations
Study of Acalabrutinib for Patients with Waldenström Macroglobulinemia
FranceStudy of Lurbinectedin and Irinotecan for Patients with Advanced Solid Tumors
FranceStudy of Latozinemab for Patients with Neurodegenerative Diseases Who Previously Participated in a Latozinemab Study
FranceStudy of sacituzumab govitecan compared to standard therapy in HER2-negative breast cancer patients with high risk of relapse after neoadjuvant treatment
FranceStudy of emactuzumab compared to placebo in patients with tenosynovial giant cell tumor
FranceStudy on Cefoxitin and Sodium Chloride for Preventing Infections After Colorectal Surgery
FranceStudy on Deferiprone for Preventing Secondary Degeneration in Stroke Patients
FranceStudy on the Safety of Vonafexor for Patients with Alport Syndrome at Risk of Progression
FranceStudy of Itolizumab with Corticosteroids for Initial Treatment of Acute Graft Versus Host Disease in Patients After Bone Marrow Transplant
FranceStudy of Palbociclib with Drug Combinations for Children and Young Adults with Recurrent or Refractory Neuroblastoma and Ewing Sarcoma
FranceStudy of Nivolumab and Ipilimumab for Patients with Type B3 Thymoma and Thymic Carcinoma After Chemotherapy
FranceStudy on Stopping Tyrosine Kinase Inhibitors in Chronic Myeloid Leukemia Patients: Comparing Dasatinib, Imatinib, Nilotinib, and Bosutinib Strategies
FranceTell us about your condition – we search every trial in Europe and connect you with the right site.
